SS Innovations International (SSII) Financials

SS Innovations International’s second-quarter 2026 results show strong revenue growth, but the company remains unprofitable and dependent on financing to offset negative operating cash flow. Revenue increased to $13.9 million from $10.0 million in the year-ago quarter, a gain of approximately 39%. Revenue also rose 25.6% from $11.1 million in the first quarter of 2026.

Gross profit improved to $7.1 million from $5.3 million in the prior quarter, although the gross margin was approximately 50.9%, down from 59.1% in the second quarter of 2025. Operating expenses remained elevated, including $4.5 million of selling, general and administrative costs, $2.4 million of research and development spending, and $2.2 million of special charges.

• Revenue growth remains a key bright spot: Q2 2026 revenue rose approximately 39% year over year and 26% sequentially, continuing the company’s multi-year expansion from the sub-$1 million quarterly revenue levels reported in 2022 to more than $13 million currently.
• Sequential operating performance improved: The operating loss narrowed to $2.3 million in Q2 2026 from $3.6 million in Q1, while the net loss improved to $2.7 million from $3.6 million.
• Gross profit increased sequentially: Gross profit climbed approximately 33% from Q1 2026 to Q2, indicating that higher sales are generating additional contribution toward operating costs.
• Liquidity is stronger than in prior years: Cash and equivalents plus restricted cash totaled approximately $22.3 million at June 30, 2026, compared with roughly $17.2 million at June 30, 2025 and less than $6 million in mid-2024.
• The balance sheet has a sizable equity cushion: Total equity was $53.4 million at the end of Q2 2026, compared with $14.8 million in Q2 2024 and only $1.1 million in Q2 2023.
• Working capital appears adequate but asset quality should be monitored: Current assets of $71.5 million exceeded current liabilities of $31.9 million, implying a current ratio of approximately 2.2. However, inventories, receivables and prepaid expenses represented a substantial portion of current assets.
• Deferred revenue is material: Current and noncurrent deferred revenue totaled approximately $12.6 million. This may support future revenue recognition, but investors should monitor whether the balance converts into cash and reported sales as expected.
• SSII continues to report recurring losses: The company posted a $2.7 million net loss in Q2 2026 and has reported net losses in each of the supplied quarterly periods. Retained earnings remained negative at approximately $62.0 million.
• Operating cash flow deteriorated sequentially: Cash used in operating activities increased to $4.2 million in Q2 2026 from $2.3 million in Q1. Continuing operating cash flow was even more negative at $9.6 million, reflecting unfavorable working-capital movements and noncash adjustments.
• Financing remains important to liquidity: Q2 financing activities provided $3.5 million, more than offsetting the company’s modest capital spending but not its operating cash use. Continued reliance on debt or other financing could increase financial risk, while weighted-average basic shares rose approximately 3.5% year over year to 200.1 million, creating potential dilution.

Overall, SSII’s growth profile is encouraging, but the financial statements still reflect an early-stage company with negative earnings, negative operating cash flow and significant accumulated losses. Investors should focus on whether revenue growth can improve margins enough to reduce cash burn without additional financing or equity issuance.